The Involvement of S100B in Alzheimer's Disease-Related Processes
abstract: Alzheimer's Disease (AD) is the sixth leading cause of death in the United States and the most common form of dementia. Its cause remains unknown, but it is known to involve two hallmark pathologies: Amyloid Beta plaques and neurofibrillary tangles (NFTs). Several proteins have been i...
Other Authors: | |
---|---|
Format: | Dissertation |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/2286/R.I.17814 |
id |
ndltd-asu.edu-item-17814 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-asu.edu-item-178142018-06-22T03:03:48Z The Involvement of S100B in Alzheimer's Disease-Related Processes abstract: Alzheimer's Disease (AD) is the sixth leading cause of death in the United States and the most common form of dementia. Its cause remains unknown, but it is known to involve two hallmark pathologies: Amyloid Beta plaques and neurofibrillary tangles (NFTs). Several proteins have been implicated in the formation of neurofibrillary tangles, including Tau and S100B. S100B is a dimeric protein that is typically found bound to Ca(II) or Zn(II). These experiments relate to the involvement of S100B in Alzheimer's Disease-related processes and the results suggest that future research of S100B is warranted. Zn(II)-S100B was found to increase the rate at which tau assembled into paired helical filaments, as well as affect the rate at which tubulin polymerized into microtubules and the morphology of SH-SY5Y neuroblastoma cells after 72 hours of incubation. Zn(II)-S100B also increased the firing rate of hippocampal neurons after 36 hours of incubation. Together, these results suggest several possibilities: Zn(II)-S100B may be a key part of the formation of paired helical filaments (PHFs) that subsequently form NFTs. Zn(II)-S100B may also be competing with tau to bind tubulin, which could lead to an instability of microtubules and subsequent cell death. This finding aligns with the neurodegeneration that is commonly seen in AD and which could be a result of this microtubule instability. Ultimately, these results suggest that S100B is likely involved in several AD-related processes, and if the goal is to find an efficient and effective therapeutic target for AD, the relationship between S100B, particularly Zn(II)-S100B, and tau needs to be further studied. Dissertation/Thesis Naegele, Hayley Golek (Author) Mcgregor, Wade C (Advisor) Baluch, Debra (Committee member) Francisco, Wilson (Committee member) Arizona State University (Publisher) Biochemistry Alzheimer's Disease S100B Tau Tubulin Zinc eng 47 pages M.S. Applied Biological Sciences 2013 Masters Thesis http://hdl.handle.net/2286/R.I.17814 http://rightsstatements.org/vocab/InC/1.0/ All Rights Reserved 2013 |
collection |
NDLTD |
language |
English |
format |
Dissertation |
sources |
NDLTD |
topic |
Biochemistry Alzheimer's Disease S100B Tau Tubulin Zinc |
spellingShingle |
Biochemistry Alzheimer's Disease S100B Tau Tubulin Zinc The Involvement of S100B in Alzheimer's Disease-Related Processes |
description |
abstract: Alzheimer's Disease (AD) is the sixth leading cause of death in the United States and the most common form of dementia. Its cause remains unknown, but it is known to involve two hallmark pathologies: Amyloid Beta plaques and neurofibrillary tangles (NFTs). Several proteins have been implicated in the formation of neurofibrillary tangles, including Tau and S100B. S100B is a dimeric protein that is typically found bound to Ca(II) or Zn(II). These experiments relate to the involvement of S100B in Alzheimer's Disease-related processes and the results suggest that future research of S100B is warranted. Zn(II)-S100B was found to increase the rate at which tau assembled into paired helical filaments, as well as affect the rate at which tubulin polymerized into microtubules and the morphology of SH-SY5Y neuroblastoma cells after 72 hours of incubation. Zn(II)-S100B also increased the firing rate of hippocampal neurons after 36 hours of incubation. Together, these results suggest several possibilities: Zn(II)-S100B may be a key part of the formation of paired helical filaments (PHFs) that subsequently form NFTs. Zn(II)-S100B may also be competing with tau to bind tubulin, which could lead to an instability of microtubules and subsequent cell death. This finding aligns with the neurodegeneration that is commonly seen in AD and which could be a result of this microtubule instability. Ultimately, these results suggest that S100B is likely involved in several AD-related processes, and if the goal is to find an efficient and effective therapeutic target for AD, the relationship between S100B, particularly Zn(II)-S100B, and tau needs to be further studied. === Dissertation/Thesis === M.S. Applied Biological Sciences 2013 |
author2 |
Naegele, Hayley Golek (Author) |
author_facet |
Naegele, Hayley Golek (Author) |
title |
The Involvement of S100B in Alzheimer's Disease-Related Processes |
title_short |
The Involvement of S100B in Alzheimer's Disease-Related Processes |
title_full |
The Involvement of S100B in Alzheimer's Disease-Related Processes |
title_fullStr |
The Involvement of S100B in Alzheimer's Disease-Related Processes |
title_full_unstemmed |
The Involvement of S100B in Alzheimer's Disease-Related Processes |
title_sort |
involvement of s100b in alzheimer's disease-related processes |
publishDate |
2013 |
url |
http://hdl.handle.net/2286/R.I.17814 |
_version_ |
1718700039105150976 |